J&J's Win In Opioid Health Insurance Class Action Is Affirmed
Johnson & Johnson and Actavis knocked down class claims over their alleged roles in fueling the opioid epidemic after a New Jersey state appellate panel on Friday said a trial judge...To view the full article, register now.
Already a subscriber? Click here to view full article